Variable | Forward stepwise | Backward stepwise | ||
---|---|---|---|---|
 | HRa(95% CIb) | p | HR (95% CI) | p |
Location of tumor | Â | 0.085 | Â | 0.001* |
 Head | - |  | 1 |  |
 Body and tail | - |  | 2.452 (1.414-4.253) |  |
Differentiation | Â | 0.001* | Â | <0.001* |
 Well | 1 |  | 1 |  |
 Moderate | 2.368 (1.120-5.007) | 0.024* | 2.163 (0.994-4.706) | 0.052 |
 Poor | 6.603 (2.515-17.338) | <0.001* | 7.076 (2.655-18.857) | <0.001* |
TNM staging | Â | 0.175 | Â | 0.014* |
 IA + IB | - |  | 1 |  |
 IIA | - | 0.929 | 3.395 (1.414-8.148) | 0.006* |
 IIB | - | 0.922 | 3.551 (1.523-8.277) | 0.003* |
 III + IV | - | 0.077 | 4.218 (1.652-10.768) | 0.003* |
Serum CA19-9 (kU/L) | Â | 0.021* | Â | 0.008* |
 ≤ 39 | 1 |  | 1 |  |
 > 39 | 1.914 (1.105-3.318) |  | 2.817 (1.313-6.043) |  |
Serum CA50 (kU/L) | Â | 0.535 | Â | 0.085 |
 ≤ 25 | - |  | 1 |  |
 > 25 | - |  | 0.552 (0.280-1.086) |  |
Serum CEA (μg/L) |  | 0.265 |  | 0.089 |
 ≤ 4.3 | - |  | 1 |  |
 > 4.3 | - |  | 1.554 (0.934-2.584) |  |
MUC4 (2-ΔCt) |  | 0.001* |  | 0.010* |
 Low (<0.056) | 1 |  | 1 |  |
 High (≥0.056) | 2.281 (1.415-3.677) |  | 1.976 (1.174-3.326) |  |
MUC4/Y (2-ΔCt) |  | 0.067 |  | 0.243 |
 Low (<0.0044) | - |  | - |  |
 High (≥0.0044) | - |  | - |  |